Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Cymabay Therapeutics Inc buy BiotechBee

Cymabay Therapeutics Inc
Start price
€15.70
12.11.23 / 70%
Target price
€20.00
31.03.26
Performance (%)
89.81%
End price
€29.80
17.02.24
Summary
This prediction ended on 17.02.24 with a price of €29.80. The BUY prediction by BiotechBee for Cymabay Therapeutics Inc saw massive gains of 89.81%. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m
Cymabay Therapeutics Inc - -
iShares Core DAX® -0.552% 3.281%
iShares Nasdaq 100 -1.415% 4.535%
iShares Nikkei 225® -0.877% -1.739%
iShares S&P 500 -0.415% 3.239%

According to BiotechBee what are the pros and cons of Cymabay Therapeutics Inc for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Cymabay Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 89.81%
Target price 20.000
Change
Ends at 31.03.26

Buy mit Kursziel 20,0

BiotechBee 
0
Report Share
12.11.23
In the thread Trading Cymabay Therapeutics Inc
Prediction Buy
Perf. (%) 89.81%
Target price 20.000
Change
Ends at 31.03.26

Buy beendet

BiotechBee 
0
Report Share
17.02.24

Stopped prediction by BiotechBee for Cymabay Therapeutics Inc

buy
Cymabay Therapeutics Inc

Start price
Target price
Perf. (%)
€6.95
24.06.23
€20.00
31.03.26
101.44%
01.10.23

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 60%